NCT07599956

Brief Summary

The main goal of this project is to see if RADAR (a machine-learning AI model) can help make rheumatic heart disease (RHD) screening easier to expand. Specifically, the project will test whether RADAR can screen as accurately-or more accurately-than current methods, and whether it can be used effectively in different low-resource settings. The aim is to show that RADAR could be adopted and used widely around the world.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P50-P75 for not_applicable

Timeline
24mo left

Started Jun 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 14, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 20, 2026

Completed
12 days until next milestone

Study Start

First participant enrolled

June 1, 2026

Expected
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2028

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2028

Last Updated

May 20, 2026

Status Verified

May 1, 2026

Enrollment Period

2 years

First QC Date

May 14, 2026

Last Update Submit

May 14, 2026

Conditions

Keywords

Rheumatic heart disease

Outcome Measures

Primary Outcomes (1)

  • Accuracy of Provider RHD Screening

    The number of correctly identified (positive or negative) screenings divided by the total number of exams.

    1 year

Secondary Outcomes (1)

  • Interpretation Sensitivity

    6 months

Study Arms (2)

Standard non-AI echocardiography

NO INTERVENTION

In the Standard non-AI Echocardiography arm, participants will receive the current standard of care under the ADUNU program, which includes a single parasternal long-axis view with black-and-white and color Doppler imaging. Providers have been trained to recognize mitral regurgitation greater than 1.5 or 2 cm (based on person's age38), any aortic insufficiency, qualitatively reduced left ventricular systolic function, and pericardial effusion. Detection of any of these findings constitutes a screen positive, prompting referral for a confirmatory echocardiogram.

RADAR-AI-assisted echocardiography

EXPERIMENTAL

In the RADAR-AI-Assisted Echocardiography arm, participants will undergo AI-assisted screening according to the well-established RADAR protocol including the same image acquisition protocol but interpreted by the tablet-based software based on two independent AI algorithms 1) RHD positive or negative and 2) mitral regurgitation jet length. Positive findings from either algorithm constitutes a screen positive. Providers may also refer for other concerns.

Diagnostic Test: AI assisted echocardiography

Interventions

Continue standard of care with AI-assisted echocardiography

RADAR-AI-assisted echocardiography

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Employed at a participating ADUNU facility
  • Holds a designated role in the ADUNU program as a nurse screener

You may not qualify if:

  • None. The pragmatic trial design includes all eligible staff at participating facilities.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Uganda Heart Institute

Kampala, Uganda

Location

MeSH Terms

Conditions

Rheumatic Heart Disease

Condition Hierarchy (Ancestors)

Rheumatic FeverStreptococcal InfectionsGram-Positive Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfectionsHeart DiseasesCardiovascular Diseases

Study Officials

  • Andrea Beaton

    Children's Hospital Medical Center, Cincinnati

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Masking Details
Cardiologists who make up the adjudication panel.
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: Following informed consent, providers will be randomized using the computer-generated online randomization module in REDCap, housed at Cincinnati Children's. Randomization will use permuted blocks with no stratification. Of the 52 providers enrolled, 26 will be assigned to each study arm-AI-assisted echocardiography or standard non-AI echocardiography-in a 1:1 ratio.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 14, 2026

First Posted

May 20, 2026

Study Start (Estimated)

June 1, 2026

Primary Completion (Estimated)

June 1, 2028

Study Completion (Estimated)

June 1, 2028

Last Updated

May 20, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations